正在加载视频...

视频加载失败

返回首页

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot...

rxmeds_store's profile picture

RXMEDS.STORE

13,603 subscribers

37,820 次观看 • 3 个月前 •via X (Twitter)

健康养生
LIVE

Anya Rossi• Live Now

Private livecam show

9 条评论

Change 的头像
Change3 个月前

I need to up my dosage I guess

Josie 的头像
Josie3 个月前

How about FENBENDAZOLE and mebendazole doses for 60 kg woman?

Angels_amongus 的头像
Angels_amongus3 个月前

@RxMeds_store , With all those different Mgs, you don't explain is it Ivermectin or Fenben, or Menben so no use to public. 5mgs of what? 20 mgs of what?

cleveland1845 的头像
cleveland18453 个月前

What about prostate cancer and adp therapy, plus ivermectin and mebendozole? Results?

Angenette McAdoo 的头像
Angenette McAdoo3 个月前

How can I connect with Dr. Makis to be seen as a patient. I live in North Carolina.

Linda Kersman 的头像
Linda Kersman3 个月前

I occasionally watch the guy on the left. I am currently taking 12 MG. 3 capsules a day for 4 days, then 3 days off, then 4 days on with 1 capsules of 222 mg. Fenbendazole. I repeat this pattern.

Elena 的头像
Elena3 个月前

My husband is on Dr. Makis protocol for 4 months and the tumor has grown and spread to the bones.

ronij 的头像
ronij3 个月前

Are specialists on board with ivermectin? Amd how much is it. I’m in Australia so I’m not sure this is happening here?

gregory harris 的头像
gregory harris3 个月前

❤️❤️❤️🔥🔥🔥

相关视频

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds
5:47

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

20,168 次观看 • 3 个月前

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
5:47

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

RXMEDS.STORE

367,946 次观看 • 2 个月前

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose Joe Tippens Protocol Email: joetippenscare@gmail.com WhatsApp: +1 (410) 422-1311 . Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD
5:47

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose Joe Tippens Protocol Email: [email protected] WhatsApp: +1 (410) 422-1311 . Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD

Joe Tippens Protocol

159,585 次观看 • 10 天前

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!
5:47

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

PharmacyinUSA

51,400 次观看 • 4 个月前

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 次观看 • 1 年前

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch
4:26

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch

RXMEDS.STORE

26,956 次观看 • 12 天前

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.
5:47

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.

Commentary | Global Ivermectin Research Hub

102,655 次观看 • 5 个月前

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 次观看 • 2 个月前

After a year of research, Dr. William Makis says this is the most important graph of his career. The ivermectin dosing schedule for cancer. For most cancers breast, colon, lung, pancreatic, renal, gastric, leukemias: Start at 1 mg per kg of body weight per day. For a 60 kg person: 60 mg daily. That's five 12 mg pills, or 6 mL of liquid. The evidence he cites is dose-dependent: 📉 Dr. Shankara Chetty prostate cancer patient's PSA dropped from 89 to 11 on 45 mg/day 📉 Dr. Tess Lawrie ovarian cancer marker CA-125 dropped from 288 to 22 on just 0.2 mg/kg 🧒 Castro study children with leukemia, no side effects after 6 months at 1 mg/kg For aggressive cancers (pancreatic, brain), the blood-brain barrier may need more: 🔹 Dr. Landrito's colleague — terminal gallbladder cancer, cancer disappeared after 14 months at 2 mg/kg/day 🔹 Highest documented dose: 2.5 mg/kg (Dr. Chetty) only transient visual side effects that resolved Why won't oncology offer this? Ivermectin is generic. Off-patent. Unprofitable. No funded trials. No incentive. No profit. Dr. Makis's conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." He suggests starting at 1 mg/kg/day. It can be taken for many months even over a year with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf. ⚠️ Not medical advice these are case reports and anecdotal evidence, not completed clinical trials. Never self-prescribe. Work with a doctor who listens.
5:46

After a year of research, Dr. William Makis says this is the most important graph of his career. The ivermectin dosing schedule for cancer. For most cancers breast, colon, lung, pancreatic, renal, gastric, leukemias: Start at 1 mg per kg of body weight per day. For a 60 kg person: 60 mg daily. That's five 12 mg pills, or 6 mL of liquid. The evidence he cites is dose-dependent: 📉 Dr. Shankara Chetty prostate cancer patient's PSA dropped from 89 to 11 on 45 mg/day 📉 Dr. Tess Lawrie ovarian cancer marker CA-125 dropped from 288 to 22 on just 0.2 mg/kg 🧒 Castro study children with leukemia, no side effects after 6 months at 1 mg/kg For aggressive cancers (pancreatic, brain), the blood-brain barrier may need more: 🔹 Dr. Landrito's colleague — terminal gallbladder cancer, cancer disappeared after 14 months at 2 mg/kg/day 🔹 Highest documented dose: 2.5 mg/kg (Dr. Chetty) only transient visual side effects that resolved Why won't oncology offer this? Ivermectin is generic. Off-patent. Unprofitable. No funded trials. No incentive. No profit. Dr. Makis's conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." He suggests starting at 1 mg/kg/day. It can be taken for many months even over a year with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf. ⚠️ Not medical advice these are case reports and anecdotal evidence, not completed clinical trials. Never self-prescribe. Work with a doctor who listens.

TheSkyMeds | Cancer & Parasites Explained

13,257 次观看 • 23 天前

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds
3:57

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds

RXMEDS.STORE

14,786 次观看 • 16 天前

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole
5:52

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

91,716 次观看 • 4 个月前

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds
5:47

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,415 次观看 • 4 个月前

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.
5:47

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.

Camus

840,494 次观看 • 1 年前

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.
5:47

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.

Dr. David

19,337 次观看 • 2 天前

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin
1:02

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

PharmacyinUSA

45,592 次观看 • 3 个月前

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 次观看 • 3 个月前

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch
1:42

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

RXMEDS.STORE

34,814 次观看 • 1 个月前

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch
4:02

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

57,224 次观看 • 14 天前